Article Details
Retrieved on: 2022-11-03 13:42:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Human monoclonal antibodies against the COVID-19 virus that were isolated in the Vanderbilt Vaccine Center in early 2020 were optimized by AstraZeneca ...
Article found on: news.vumc.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here